4-[(E)-2-(2-Octyl-thiochroman-6-yl)-propenyl]-benzoic acid ethyl ester

ID: ALA120980

PubChem CID: 10718405

Max Phase: Preclinical

Molecular Formula: C29H38O2S

Molecular Weight: 450.69

Molecule Type: Small molecule

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  CCCCCCCCC1CCc2cc(/C(C)=C/c3ccc(C(=O)OCC)cc3)ccc2S1

Standard InChI:  InChI=1S/C29H38O2S/c1-4-6-7-8-9-10-11-27-18-16-26-21-25(17-19-28(26)32-27)22(3)20-23-12-14-24(15-13-23)29(30)31-5-2/h12-15,17,19-21,27H,4-11,16,18H2,1-3H3/b22-20+

Standard InChI Key:  AZQBNTMXFDQFCZ-LSDHQDQOSA-N

Molfile:  

     RDKit          2D

 32 34  0  0  0  0  0  0  0  0999 V2000
    2.0792   -4.4667    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    4.9292   -2.8000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.7875   -4.0500    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.6417   -3.2042    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.2167   -3.2167    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.7792   -3.2167    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.4917   -1.5500    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.5000   -2.8042    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.7792   -1.9667    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.4875   -0.7250    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.5000   -4.4542    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.2167   -4.0417    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.0667   -2.8167    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.3542   -2.7917    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.7792   -2.7917    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.0542   -1.5542    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.3542   -4.0542    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.2042   -1.9542    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    7.0667   -3.2042    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.3500   -1.9750    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.3542   -3.2292    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.9250   -1.9750    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.9167   -1.5417    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.6417   -4.4750    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0708   -4.0667    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.6375   -4.4917    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.9250   -4.0792    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.2083   -4.4875    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7833   -4.4792    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4958   -4.0667    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.6375   -1.9542    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.3583   -4.0875    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  2  5  1  0
  3  1  1  0
  4  2  2  0
  5 12  1  0
  6  3  2  0
  7  9  1  0
  8  6  1  0
  9 16  1  0
 10  7  2  0
 11  3  1  0
 12 11  2  0
 13 21  1  0
 14  4  1  0
 15 19  1  0
 16 20  2  0
 17  1  1  0
 18  7  1  0
 19 14  2  0
 20 14  1  0
 21 17  1  0
 22  2  1  0
 23 18  1  0
 24 17  1  0
 25 24  1  0
 26 27  1  0
 27 28  1  0
 28 30  1  0
 29 25  1  0
 30 29  1  0
 31 23  1  0
 32 26  1  0
  6 13  1  0
  5  8  2  0
 15  9  2  0
M  END

Associated Targets(Human)

SCC-38 (21 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

SCC-2 (20 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 450.69Molecular Weight (Monoisotopic): 450.2593AlogP: 8.58#Rotatable Bonds: 11
Polar Surface Area: 26.30Molecular Species: HBA: 3HBD:
#RO5 Violations: 1HBA (Lipinski): 2HBD (Lipinski): #RO5 Violations (Lipinski): 1
CX Acidic pKa: CX Basic pKa: CX LogP: 9.48CX LogD: 9.48
Aromatic Rings: 2Heavy Atoms: 32QED Weighted: 0.19Np Likeness Score: -0.06

References

1. Benbrook DM, Madler MM, Spruce LW, Birckbichler PJ, Nelson EC, Subramanian S, Weerasekare GM, Gale JB, Patterson MK, Wang B, Wang W, Lu S, Rowland TC, DiSivestro P, Lindamood C, Hill DL, Berlin KD..  (1997)  Biologically active heteroarotinoids exhibiting anticancer activity and decreased toxicity.,  40  (22): [PMID:9357524] [10.1021/jm970196m]
2. Zacheis D, Dhar A, Lu S, Madler MM, Klucik J, Brown CW, Liu S, Clement F, Subramanian S, Weerasekare GM, Berlin KD, Gold MA, Houck JR, Fountain KR, Benbrook DM..  (1999)  Heteroarotinoids inhibit head and neck cancer cell lines in vitro and in vivo through both RAR and RXR retinoic acid receptors.,  42  (21): [PMID:10543887] [10.1021/jm990292i]

Source